Latest review
First review round: 3.3 weeks. Overall rating: 4 (very good).
Outcome: Rejected.
Motivation:
We received two reviewer reports from Molecular Pharmaceutics. The first reviewer advised the editor to accept the manuscripts with minor changes. Reviewer two advised the manuscript should be sent to another journal. The Associate Editor, based on the two reports, decided then to reject the manuscript. However, both reviewers, specially reviewer one, had great comments on our manuscript's contents, which will improve greatly the quality of our work.
